All In MedTech

Device Trial Radar · NCT03898960

Post Marketing Study to Evaluate the NIMBUS Device

Post Marketing Study of Patients to Evaluate NIMBUS Revascularization Effectiveness With Challenging Occlusions

Last checked: Nov 20, 2026Latest source record: Apr 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

54

Actual

Start

Oct 30, 2019

Primary completion

Feb 15, 2022

Study completion Apr 8, 2022

Sponsor

Lead sponsor
Neuravi LimitedNot on our public-company list
Sponsor type
Industry
First posted
Apr 2, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A post-market study evaluating the NIMBUS Device in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.

Conditions

  • Cerebral Stroke

Interventions

  • NIMBUS DeviceDevice

    NIMBUS Geometric Clot Extractor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Successful Revascularization With NIMBUS DeviceTime frame: Day 1

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • UKE Hamburg

    Hamburg, Germany

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.